Forward Pharma A/S FWP

$ 2.64 -0.75%

Annual report 2021
added 12-23-2023

Forward Pharma A/S Balance Sheet 2011-2024 | FWP

Annual Balance Sheet Forward Pharma A/S

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-	-	-	-57.9 M	-52.3 M	-45.3 M	-342 K	1.27 M	-427 K
Long Term Debt	-	-	-	-	-	-	-	-	-	2.1 M	-
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	43 K	-	-	-	-	2.1 M	-
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	1.07 M	596 K	1.12 M	21.3 M	7.34 M	6.21 M	2.92 M	30 M	21.2 M	1.26 M
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-14.8 M	-8.43 M	-5.69 M	-2.37 M	-147 M	-131 M	-108 M	-51.9 M	-36.8 M	-14.8 M
Total Assets	71.4 M	79.7 M	78.2 M	83.3 M	111 M	163 M	183 M	225 M	3.6 M	970 K	1.55 M
Cash and Cash Equivalents	70.8 M	79.1 M	77.6 M	82.5 M	110 M	57.9 M	52.3 M	-	-	-	-
Book Value	71.4 M	78.6 M	77.6 M	82.2 M	89.7 M	156 M	177 M	222 M	-26.4 M	-20.2 M	285 K
Total Shareholders Equity	-	78.6 M	77.6 M	82.2 M	89.7 M	156 M	177 M	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Forward Pharma A/S

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	43 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-16.7 M	-	-15.9 M	-	-14.8 M	-	-	-	-8.43 M	-	-	-	-5.69 M	-	-4.32 M	-	-2.37 M	-	-	-	-147 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	71.4 M	-	75.7 M	-	79.7 M	-	-	-	78.2 M	-	-	-	83.3 M	-	90.5 M	-	111 M	-	-	-	163 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	70.8 M	-	75.1 M	-	79.1 M	-	75.6 M	-	77.6 M	-	-	-	82.5 M	-	89.3 M	-	110 M	-	1.36 B	-	57.9 M	-	-	-	52.3 M	-	-	-	45.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	71.4 M	-	75.7 M	-	79.7 M	-	-	-	78.2 M	-	-	-	83.3 M	-	90.5 M	-	111 M	-	-	-	163 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	70.8 M	-	75.1 M	-	78.6 M	-	75.5 M	-	77.6 M	-	-	-	82.2 M	-	85.2 M	-	89.7 M	-	1.17 B	-	156 M	-	-	-	177 M	-	-	-	222 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency